Borrelia garinii+afzelii oppA1 gene [Presence] in Specimen by NAA with non-probe detection
The DNA amplification target is the 283-bp plasminogen-binding protein gene (oppA1), which is present at a frequency of one copy per organism in all four pathogenic species of the Borrelia burgdorferi sensu lato genogroup (Borrelia burgdorferi sensu stricto, Borrelia afzelii, Borrelia garinii, and Borrelia mayonii). Melting curve analysis is used to differentiate B. afzelii and B. garinii from the other two species but cannot differentiate between B. afzelii and B. garinii. Potential specimens include CSF, tissue, and synovial fluid.
Source: Regenstrief LOINC
LP220480-0 Borrelia garinii+afzelii oppA1 gene
Lyme disease is a multisystem, multistage infection caused by three species of tick-borne spirochetes in the Borrelia burgdorferi sensu lato genogroup. These spirochetes include B. burgdorferi sensu stricto (North America and Western Europe), B. afzelii (Central and Western Europe and Russia), and B. garinii (Europe, Russia, and northern Asia). Endemic areas for Lyme disease in the United States correspond with the distribution of two tick species, Ixodes dammini (Northeastern and Upper Midwestern US) and Ixodes pacificus (West Coast US). In Europe, Ixodes ricinus transmits the spirochete. Human Lyme borreliosis, the most prevalent arthropod-borne infection in temperate climate zones around the world, is an inflammatory disorder characterized by the skin lesion erythema migrans and the potential development of neurologic, cardiac, and joint abnormalities. B. garinii, the most neurotropic of these three genospecies, causes most neurologic Lyme disease in Europe, including cases of meningopolyneuritis and, rarely, encephalomyelitis. Although probably all three genospecies can cause all major manifestations, it appears that infection with different B. burgdorferi sensu lato genospecies results in distinct presentations of Lyme borreliosis. In Europe, B. afzelii is mostly associated with skin manifestations, such as erythema migrans, and acrodermatitis chronica atrophicans, whereas B. garinii is the main cause of Lyme neuroborreliosis. Patients with B. garinii isolated from CSF samples have a distinct clinical presentation, compared with that of patients with B. afzelii infection. PMID: 16912943 PMID: 12454161 Source: Regenstrief LOINC
LP220480-0 Borrelia garinii+afzelii oppA1 gene
The oppA1 gene is a member of a family of three genes; oppA-1, oppA-2, and oppA-3, that encode predicted peptide-binding proteins. Peptide-binding protein dependent transport systems are recognized to play important roles in microbial cell signaling and virulence. PMID: 9712756 Source: Regenstrief LOINC
- Borrelia garinii+afzelii oppA1 gene
- Short Name
- B gar+afz oppA1 Spec Ql NAA+non-probe
- Display Name
- B. garinii+afzelii oppA1 gene NAA+non-probe Ql (Specimen)
- Consumer Name Alpha Get Info
- Borrelia garinii+afzelii oppA1 gene, Specimen
Example Answer List: LL360-9Source: Regenstrief Institute
|PositiveCopyright http://snomed.info/sct ID:10828004 Positive (qualifier value)||LA6576-8|
|NegativeCopyright http://snomed.info/sct ID:260385009 Negative (qualifier value)||LA6577-6|
- First Released
- Version 2.58
- Last Updated
- Version 2.69
- Change Reason
- Release 2.68: COMPONENT: Removed parentheses from Component for consistency and accuracy.; Previous Releases:
- Order vs. Observation
Language Variants Get Info
|es-ES||Spanish (Spain)||Gen oppA1 de Borrelia garinii+afzelii:
|es-MX||Spanish (Mexico)||Borrelia garinii + gen oppA1 de afzelii:
|fr-FR||French (France)||Borrelia garinii+afzelii oppA1 gène:
|it-IT||Italian (Italy)||Borrelia garinii+afzelii (oppA1), gene:
Synonyms: Amplificazione target non basata su sonda Gene Borrelia garinii+afzelii (oppA1) Microbiologia Presenza o Soglia Punto nel tempo (episodio) Sonda con amplificazione Sonda con amplificazione del target Sonda di DNA
|zh-CN||Chinese (China)||加里疏螺旋体+阿夫塞疏螺旋体 oppA1 基因:
LOINC Terminology Service (API) using
HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or firstname.lastname@example.org<mailto:email@example.com>. This may incur a fee in SNOMED International non-Member countries.
Copyright © 2023 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright